38 results on '"Buhl, Roland"'
Search Results
2. Asthma in Klinik und Praxis
3. In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
4. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
5. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
6. German Asthma Net – Was haben wir bisher gelernt?
7. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
8. Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany
9. Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten
10. Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® Trials
11. Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials
12. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO® and OTEMTO® Studies
13. COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
14. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”
15. ARIA guideline 2019: treatment of allergic rhinitis in the German health system
16. Use of psychosocial services by lung cancer survivors in Germany: Results of a German multicenter study (LARIS)
17. Lebensqualität von Überlebenden eines nichtkleinzelligen Lungenkarzinoms: Übersicht zu assoziierten Faktoren und Anforderungen an die Nachsorge
18. Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies
19. Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management
20. Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
21. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
22. Psychische Verfassung und psychosoziale Versorgungssituation von Überlebenden von kleinzelligem Lungenkrebs
23. Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancer
24. Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis
25. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD)
26. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies
27. Klinische Bedeutung der forcierten Einsekundenkapazität (FEV1) bei chronisch-obstruktiver Lungenerkrankung (COPD)
28. MDCT assessment of airway wall thickness in COPD patients using a new method: correlations with pulmonary function tests
29. Lungenkarzinom
30. Feste Kombination aus Budesonid und Formoterol in der Erhaltungs- und Bedarfstherapie: Ein neues Therapiekonzept für erwachsene Asthmapatienten
31. Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study
32. Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma 2005: Die wichtigsten Gesichtspunkte für das Erwachsenenalter
33. Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma
34. Bronchodilatatoren in der Dauertherapie der chronisch-obstruktiven Lungenerkrankung (COPD)
35. COPD, eine Systemerkrankung—ernährungstherapeutische Ansätze
36. Effects of Piclamilast, a Selective Phosphodiesterase-4 Inhibitor, on Oxidative Burst of Sputum Cells From Mild Asthmatics and Stable COPD Patients
37. Pathogenese des Asthma bronchiale – Eröffnung neuer therapeutischer Perspektiven
38. Anticholinergika in der Therapie der chronisch-obstruktiven Lungenerkrankung (COPD)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.